Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan
Systemic chemotherapy plays an important role in the treatment of pancreatic cancer, to improve the survival of patients with pancreatic cancer. Unresectable pancreatic cancer can be classified into three categories: metastatic, locally advanced, and hereditary pancreatic cancers. Furthermore, the s...
Main Author: | Junji Furuse |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/8/1170 |
Similar Items
-
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
by: Mariia Kiriukova, et al.
Published: (2020-09-01) -
Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience
by: Cavanna L, et al.
Published: (2019-04-01) -
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
by: Changhoon Yoo, et al.
Published: (2019-02-01) -
Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2018-11-01) -
Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)